D Choi, SK Kim, SH Choi, YG Ko, CW Ahn, Y … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Eighty-three patients (45 patients with 55 lesions in the control
group and 38 patients with 51 lesions in the rosiglitazone group) completed
follow-up angiography. Rosiglitazone treatment for 6 months reduced fasting ... Cited by 216 - Related articles - BL Direct - All 8 versions
T Takagi, A Yamamuro, K Tamita, K Yamabe, M … - American Heart Journal, 2003 - Elsevier To determine whether pioglitazone reduces neointimal tissue proliferation after
coronary stent implantation in patients with type 2 diabetes mellitus, we
studied 44 stented lesions in 44 patients with diabetes mellitus who ... Cited by 141 - Related articles - All 9 versions
- ►ahajournals.org N Marx, J Wohrle, T Nusser, D Walcher, A … - Circulation, 2005 - Am Heart Assoc Methods and Results— Fifty nondiabetic patients after coronary stent
implantation were randomly assigned to pioglitazone (30 mg daily; pio) or
placebo (control) treatment in addition to standard therapy, and neointima ... Cited by 121 - Related articles - All 8 versions
A Osman, J Otero, A Brizolara, S Waxman, G … - American Heart Journal, 2004 - Elsevier Patients with treated type 2 diabetes (mean duration 5.5 ± 7.5 years) referred
for coronary stenting were randomized in a double-blind fashion to receive oral
rosiglitazone or placebo for 6 months. Quantitative coronary angiography ... Cited by 57 - Related articles - All 8 versions
K Nishio, M Sakurai, T Kusuyama, M … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 28 patients were randomly assigned to the control group,
and 26 patients were assigned to the pioglitazone group. There were no
significant differences in glycemic control levels or in lipid levels in ... Cited by 60 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org JS Sidhu, Z Kaposzta, HS Markus, JC Kaski - Arteriosclerosis, thrombosis, and vascular biology, 2004 - Am Heart Assoc Methods and Results— Consecutive subjects (n=92) with clinically stable,
angiographically documented CAD and without diabetes mellitus were randomized in
a double-blind manner to receive placebo or rosiglitazone for 48 weeks. ... Cited by 222 - Related articles - BL Direct - All 9 versions
T Takagi, A Yamamuro, K Tamita, K Yamabe, … - The American journal of cardiology, 2002 - Elsevier Although coronary stent implantation has been shown to reduce restenosis rates
compared with balloon angioplasty, in-stent restenosis remains a significant
clinical problem, especially in patients with diabetes mellitus (DM).[1, 2, ... Cited by 64 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org MR Langenfeld, T Forst, C Hohberg, P Kann, G … - Circulation, 2005 - Am Heart Assoc Methods and Results— We compared the effects of pioglitazone-based therapy (45
mg/d) and glimepiride-based treatment (2.7±1.6 mg/d) for 12 and 24 weeks on
metabolic control (HbA 1c ), insulin resistance (homeostasis model ... Cited by 188 - Related articles - All 14 versions
- ►onlinejacc.org T Takagi, T Akasaka, A Yamamuro, Y Honda, … - Journal of the American College of Cardiology, 2000 - Elsevier We studied 62 stented lesions in 52 patients with plasma glucose levels (PG)
≥11.1 mmol/liter at 2 h after 75 g oral glucose load. The study patients were
randomized into two groups: the troglitazone group of 25 patients with 29 ... Cited by 202 - Related articles - BL Direct - All 12 versions
- ►infodiabetes.it [PDF] PD Home, SJ Pocock, H Beck-Nielsen, R … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 1726–1735 DOI 10.1007/s00125-005-1869-1 ARTICLE
PD Home . SJ Pocock . H. Beck-Nielsen . R. Gomis . M. Hanefeld . H. Dargie . ... Cited by 147 - Related articles - BL Direct - All 5 versions
